Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4103/ijpm.ijpm_477_24 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An EMT-like signature as a potential driver of myeloid sarcoma.
Blood Neoplasia
September 2024
Department of Pediatrics, Division of Hematology, Oncology, and Bone Marrow Transplantation, Medical College of Wisconsin, Milwaukee, WI, USA.
[YAP1::KMT2A fusion sclerosing epithelioid fibrosarcoma: report of a case].
Zhonghua Bing Li Xue Za Zhi
March 2025
Department of Pathology, Tianjin Hospital of Tianjin University, Tianjin 300211, China.
Spontaneous Complete Regression of Aleukaemic Cutaneous Myeloid Sarcoma without Progression to Leukaemia Over a Long-term Follow-up Period.
Acta Derm Venereol
February 2025
Department of Medicine of Sensory and Motor Organs, Division of Dermatology, Faculty of Medicine, Tottori University, Tottori, Japan.
Diagnostic Approaches in Myeloid Sarcoma.
Curr Issues Mol Biol
February 2025
Pathomorphology Laboratory, Department of Hematological Diagnostics, Institute of Hematology and Transfusion Medicine, 02-776 Warsaw, Poland.
Myeloid sarcoma (MS), or extramedullary acute myeloid leukaemia tumour (eAML), is a rare hematopoietic neoplasm. Recognised as a distinct entity within acute myeloid leukaemia (AML), MS presents significant diagnostic challenges due to its rarity, clinical heterogeneity, and variable immunophenotypic and genetic characteristics. The mechanisms by which leukaemic stem cells (LSCs) migrate to form solid tumours in extramedullary (EM) sites remain unclear.
View Article and Find Full Text PDFPrimary Splenic Isolated Myeloid Sarcoma in an Elderly Male-An Extremely Rare Presentation.
Indian J Surg Oncol
December 2024
Department of Pathology and Laboratory Medicine, AIIMS, Rishikesh, Uttarakhand Pin 249203 India.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!